{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:06:18Z","timestamp":1787846778449,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients infected with COVID-19 admitted to the intensive care unit (ICU) may have a higher incidence of developing secondary infections. These infections can further deteriorate the hospital course and increase mortality. Therefore, the objectives of this study were to investigate the incidence, associated risk factors, outcomes, and pathogens associated with secondary bacterial infections in critically ill patients with COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>All adult COVID-19 patients admitted to the intensive care unit requiring mechanical ventilation from October 1, 2020 until December 31, 2021 were screened for inclusion in the study. A total of 86 patients were screened and 65 who met the inclusion criteria were prospectively entered into a customized electronic database. The database was then retrospectively analyzed to investigate secondary bacterial infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 65 patients included, 41.54% acquired at least one of the studied secondary bacterial infections during the course of their ICU stay. The most common secondary infection (59.26%) seen was hospital-acquired pneumonia followed by acquired bacteremia of unknown origin (25.92%) and catheter-related sepsis (14.81%). Diabetes mellitus (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = &lt;.001), cumulative dose of corticosteroids (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), were associated with an increased risk of secondary bacterial infection. The most commonly isolated pathogen in patients with secondary pneumonia was\n                      <jats:italic toggle=\"yes\">Acinetobacter baumannii<\/jats:italic>\n                      .\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      was the most common organism associated with a bloodstream infection and catheter-related sepsis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The incidence of secondary bacterial infections was high in critically ill patients with COVID-19 and was associated with a longer duration of admission to the hospital and ICU and a higher mortality. Diabetes mellitus and cumulative dose of corticosteroids were associated with significantly increased risk of secondary bacterial infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/lungindia.lungindia_293_22","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T03:09:23Z","timestamp":1683169763000},"page":"210-214","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Secondary infections in critically ill patients with COVID-19: A retrospective single-center study"],"prefix":"10.4103","volume":"40","author":[{"given":"Obaid I.","family":"Haque","sequence":"first","affiliation":[{"name":"Research Fellow, Massachusetts General Hospital, Harvard Medical School, Boston, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shameem","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis and Respiratory Diseases, Jawaharlal Nehru Medical College, Aligarh, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wamin","family":"Hashim","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Critical Care, Jawaharlal Nehru Medical College, Aligarh, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.4103\/jfmpc.jfmpc_2071_20","article-title":"Viral pandemics in the past two decades:An overview","volume":"10","author":"Bhadoria","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00508-020-01760-4","article-title":"Clinical manifestations of COVID-19 in the general population:Systematic review","volume":"133","author":"da Rosa Mesquita","year":"2021","journal-title":"Wien Klin Wochenschr"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states:A clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19:Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1080\/22221751.2020.1812437","article-title":"Risks and features of secondary infections in severe and critical ill COVID-19 patients","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"R8-20240828","first-page":"359","article-title":"Bacterial coinfections in COVID-19:An underestimated adversary","volume":"56","author":"Fattorini","year":"2020","journal-title":"Ann Ist Super Sanita"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13054-021-03672-9","article-title":"Secondary infections in critically ill patients with COVID-19","volume":"25","author":"Grasselli","year":"2021","journal-title":"Critical Care"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00134-020-06323-9","article-title":"Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections:A European multicenter cohort study","volume":"47","author":"Rouz\u00e9","year":"2021","journal-title":"Intensive Care Med"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"e13319","DOI":"10.1111\/eci.13319","article-title":"Bloodstream infections in critically ill patients with COVID-19","volume":"50","author":"Giacobbe","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00134-021-06346-w","article-title":"COVID-19 increased the risk of ICU-acquired bloodstream infections:A case-cohort study from the multicentric OUTCOMEREA network","volume":"47","author":"Buetti","year":"2021","journal-title":"Intensive Care Med"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement:Guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"(Suppl 2)","key":"R15-20240828","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/irv.12089","article-title":"Bacterial and viral infections associated with influenza","volume":"7","author":"Joseph","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia:A descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jinf.2011.04.004","article-title":"Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease","volume":"63","author":"Esper","year":"2011","journal-title":"J Infect"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/irv.12398","article-title":"The frequency of influenza and bacterial coinfection:A systematic review and meta-analysis","volume":"10","author":"Klein","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.jinf.2020.09.010","article-title":"Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19","volume":"82","author":"Soriano","year":"2021","journal-title":"J Infect"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave:The French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/ijp.ijp_419_21","article-title":"Rhino-orbital-cerebral-mucormycosis in COVID-19:A systematic review","volume":"53","author":"Bhattacharyya","year":"2021","journal-title":"Indian J Pharmacol"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/LBR.0000000000000681","article-title":"American association for bronchology and interventional pulmonology (AABIP) statement on the use of bronchoscopy and respiratory specimen collection in patients with suspected or confirmed COVID-19 infection","volume":"27","author":"Wahidi","year":"2020","journal-title":"J Bronchology Interv Pulmonol"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","article-title":"Diagnosing COVID-19-associated pulmonary aspergillosis","volume":"1","author":"Verweij","year":"2020","journal-title":"Lancet Microbe"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkv419","article-title":"1,3-b-d-Glucan contamination of common antimicrobials","volume":"71","author":"Liss","year":"2016","journal-title":"J Antimicrobial Chemotherapy"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(00)02291-1","article-title":"Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care","volume":"355","author":"Eggimann","year":"2000","journal-title":"Lancet"},{"issue":"(Suppl 1)","key":"R28-20240828","first-page":"S27","article-title":"Infections in patients with diabetes mellitus:A review of pathogenesis","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"104354","DOI":"10.1016\/j.jcv.2020.104354","article-title":"Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome","volume":"127","author":"Roncon","year":"2020","journal-title":"J Clin Virol"}],"container-title":["Lung India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/lungindia.lungindia_293_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:06:37Z","timestamp":1787760397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/lungindia.lungindia_293_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/lungindia.lungindia_293_22","relation":{},"ISSN":["0970-2113","0974-598X"],"issn-type":[{"value":"0970-2113","type":"print"},{"value":"0974-598X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"2022-06-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}